Skip to content
Tenfell
Awarded contract
Published 21 Aug 2023

Investigational Medicinial Product (IMP) - IM Woman Trial

London School of Hygiene & Tropical Medicine · London

Key facts

Contract value
£1,066,444
Awarded
09 Aug 2023
Contract starts
09 Aug 2023
Contract ends
31 Aug 2025
Procedure
Open procedure
Buyer type
Education

Awarded to

SupplierValue
Sharp Clinical Services (UK) Ltd£1,066,444

Description

Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.

A randomised, triple-blind, three-arm, non-inferiority trial to assess the efficacy and safety of intramuscular tranexamic acid compared to intravenous tranexamic acid and placebo in women having vvaginal and caesarean section births.

Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).

Provision of treatment kit boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months commencing March 2023.

Categories (CPV)

Similar open tenders

About London School of Hygiene & Tropical Medicine

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.